Access cutting-edge histologically confirmed relapsed or refractory b-cell non-hodgkin lymphoma treatment through this clinical trial at a research site in Nashville. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Nashville location
Preparing your pre-screening questions…
Access histologically confirmed relapsed or refractory b-cell non-hodgkin lymphoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related histologically confirmed relapsed or refractory b-cell non-hodgkin lymphoma treatment provided free
Check if you qualify for this histologically confirmed relapsed or refractory b-cell non-hodgkin lymphoma clinical trial in Nashville, TN
No-Cost Study Care
Local to Nashville
Convenient for TN residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
A Phase 1/2 study to evaluate safety, tolerability, and anticancer activity of TORL-5-700 as a monotherapy and in combination in R/R NHL
Sponsor: TORL Biotherapeutics, LLC
Yes, this clinical trial (NCT07439653) has an active research site in Nashville, TN that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for histologically confirmed relapsed or refractory b-cell non-hodgkin lymphoma treatment options in Nashville, TN, this clinical trial (NCT07439653) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Nashville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced histologically confirmed relapsed or refractory b-cell non-hodgkin lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all histologically confirmed relapsed or refractory b-cell non-hodgkin lymphoma clinical trials near you to find additional studies recruiting in your area.
See all leukemia clinical trials recruiting in Nashville — not just this study.
Browse Leukemia Trials in Nashville →